BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4113434)

  • 1. Cell-mediated immunity in malignant melanoma.
    Cochran AJ; Jehn UW; Gothoskar BP
    Lancet; 1972 Jun; 1(7764):1340-1. PubMed ID: 4113434
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunologic mechanisms in malignant melanoma of the skin.
    Cochran AJ
    Trans Ophthalmol Soc U K (1962); 1977 Sep; 97(3):385-8. PubMed ID: 347641
    [No Abstract]   [Full Text] [Related]  

  • 3. The cell-mediated immunity in patients with malignant melanoma.
    Fixa B; Komárková O; Kraus Z; Simková H
    Neoplasma; 1978; 25(3):353-7. PubMed ID: 683378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-directed cellular immunity in malignant melanoma and its modification by surgical treatment.
    Cochran AJ; Thomas CE; Spilg WG; Grant RM; Cameron-Mowat DE; Mackie RM; Lindop G
    Yale J Biol Med; 1973 Dec; 46(5):650-4. PubMed ID: 4779137
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunology and immunotherapy of human-malignant melanoma: historic review and perspectives for the future.
    Gutterman JU; Mavligit G; Reed R; Richman S; McBride CE; Hersh EM
    Semin Oncol; 1975 Jun; 2(2):155-74. PubMed ID: 790574
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cellular immunity in melanomalignome (author's transl)].
    Fritz J; Grond K; Tilz GP
    Arch Dermatol Res (1975); 1976 Apr; 255(2):203-9. PubMed ID: 1275554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of natural cytotoxicity and the leukocyte migration inhibition in human melanoma stages I and II.
    Kristensen E
    J Cancer Res Clin Oncol; 1980; 96(2):181-91. PubMed ID: 7391115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of cellular mediated immunity in malignant melanoma patients by Leukocyte Adherence Inhibition Test.
    Müller S; Ernst TM
    Arch Dermatol Res; 1980; 268(2):167-81. PubMed ID: 7425670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunotherapy].
    Lejeune FJ; Bernheim JL; Vanwijck R
    Acta Chir Belg; 1974 Mar; 73(2):265-93. PubMed ID: 4450923
    [No Abstract]   [Full Text] [Related]  

  • 10. [Evaluation of cellular immunity in melanoma by means of a modified leukocyte migration inhibition test].
    Bowszyc J; Bowszyc J; Wojnerowicz-Grajewska M; Milanowski L
    Przegl Dermatol; 1980; 67(3):319-23. PubMed ID: 6968922
    [No Abstract]   [Full Text] [Related]  

  • 11. Proceedings: cellular immunity to malignant melanoma.
    Grant RM; Cochran AJ; Thomas CE; Mackie RM; Cameron-Mowat DE; Spilg WG; Norman JN
    Br J Surg; 1973 Nov; 60(11):905. PubMed ID: 4752760
    [No Abstract]   [Full Text] [Related]  

  • 12. Cell-mediated immunity in patients with malignant melanoma.
    Mackie RM; Spilg WG; Thomas CE; Cochran AJ
    Br J Dermatol; 1972 Dec; 87(6):523-8. PubMed ID: 4648800
    [No Abstract]   [Full Text] [Related]  

  • 13. Cell-mediated immunity to melanoma-associated antigens in patients with ocular malignant melanoma.
    Char DH; Jerome L; McCoy JL; Herberman RB
    Am J Ophthalmol; 1975 May; 79(5):812-6. PubMed ID: 1146943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demonstration of cellular immunity to tumor-specific antigens of malignant melanoma in hamsters by inhibition of macrophage migration.
    Henderson WR; Fukuyama K; Epstein WL; Spitler LE
    J Invest Dermatol; 1972 Apr; 58(4):229-32. PubMed ID: 5020976
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunologic response in patients with melanoma of the skin].
    Mutsenietse AIa; Volrat AA; Popena BA; Bumbieris IaV; Shapovalova EA
    Vopr Onkol; 1983; 29(4):34-8. PubMed ID: 6858048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular immunity to breast carcinoma and malignant melanoma.
    Cochran AJ; Mackie RM; Thomas CE; Grant RM; Cameron-Mowat DE; Spilg WG
    Br J Cancer Suppl; 1973 Aug; 1():77-82. PubMed ID: 4804293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Modification of a micromethod for determining leukocyte migration inhibition and its significance in oncological patients].
    Kochetkova VA
    Lab Delo; 1980; (12):744-6. PubMed ID: 6163894
    [No Abstract]   [Full Text] [Related]  

  • 18. Human malignant melanoma antigenic properties of phenol water extracts.
    Suter L; Tilkorn H; Kövary PM
    Arch Dermatol Res; 1979 Feb; 264(1):37-47. PubMed ID: 443860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The characterization of tumour-associated membrane-bound antigens and their implementation in the treatment of malignant melanoma (author's transl)].
    Kokoschka EM
    Wien Klin Wochenschr Suppl; 1979; 97():3-32. PubMed ID: 106559
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of leukocyte migration with melanoma-associated antigens in choroidal tumors.
    Char DH
    Invest Ophthalmol Vis Sci; 1977 Feb; 16(2):176-9. PubMed ID: 832980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.